Pfizer-BioNTech Covid-19 Vaccine for Young Kids Satisfied FDA Criteria, Agency Says
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson...
Johnson & Johnson’s JNJ 2.55% sales climbed in the latest quarter compared with the same stretch of last year, reflecting...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
WASHINGTON—Supply-chain disruptions and global health concerns spurred the International Monetary Fund to lower its 2021 growth forecast for the world...
Johnson & Johnson’s JNJ -0.42% top scientist, who oversaw a turnaround in the company’s pharmaceutical unit and the development of...
Merck & Co. and partner Ridgeback Biotherapeutics LP said Monday they have filed an application asking U.S. health regulators to...
Contract drug manufacturer Catalent Inc. is expected to announce Monday that it has agreed to buy closely held Bettera Holdings...
Concerts’ long-anticipated comeback this fall is stumbling, as more big-name artists cancel their tours and other musicians are coping with...
Theranos Inc. once symbolized how Silicon Valley’s hustle and innovation might revolutionize healthcare. Its collapse made it a cautionary tale...
Johnson & Johnson said Wednesday that a second dose of its Covid-19 vaccine was found in a study to generate...
The Biden administration took steps Wednesday to crack down on rising Covid-19 cases, including a call for a third shot...